TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL

被引：0
|
作者：
E Fronkova
J Madzo
J Zuna
L Reznickova
K Muzikova
O Hrusak
J Stary
J Trka
机构：
[1] 2nd Medical School,CLIP – Childhood Leukaemia Investigation Prague
[2] Charles University,Department of Paediatric Haematology/Oncology
[3] 2nd Medical School,Department of Immunology
[4] Charles University,undefined
[5] 2nd Medical School,undefined
[6] Charles University,undefined
来源：
Leukemia | 2005年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1296 / 1297
页数：1
相关论文
共 50 条
  • [1] TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL
    Fronkova, E
    Madzo, J
    Zuna, J
    Reznickova, L
    Muzikova, K
    Hrusak, O
    Stary, J
    Trka, J
    LEUKEMIA, 2005, 19 (07) : 1296 - 1297
  • [2] Quantitation of minimal residual disease (MRD) in TEL/AML1 positive patients during treatment by real-time quantitative RT-PCR (RQ-PCR)
    Ballerini, P
    Landman-Parker, J
    Blaise, A
    Laurendeau, I
    Vidaud, M
    Adam, M
    Auvrignon, A
    Leverger, G
    Douay, L
    Cayre, YE
    Bièche, I
    LEUKEMIA, 2001, 15 (12) : 2018 - 2018
  • [3] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
    S Viehmann
    A Teigler-Schlegel
    J Bruch
    C Langebrake
    D Reinhardt
    J Harbott
    Leukemia, 2003, 17 : 1130 - 1136
  • [4] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
    Viehmann, S
    Teigler-Schlegel, A
    Bruch, J
    Langebrake, C
    Reinhardt, D
    Harbott, J
    LEUKEMIA, 2003, 17 (06) : 1130 - 1136
  • [5] Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts
    Takenokuchi, M
    Yasuda, C
    Takeuchi, K
    Nakamachi, Y
    Mukai, M
    Kondo, S
    Kumagai, S
    Saigo, K
    Murayama, T
    Koizumi, T
    Tatsumi, E
    CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (02): : 107 - 114
  • [6] Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia
    Ballerini, P
    Parker, JL
    Laurendeau, I
    Olivi, M
    Vidaud, M
    Leverger, G
    Gerota, I
    Cayre, YE
    Bièche, I
    LEUKEMIA, 2000, 14 (08) : 1526 - 1528
  • [7] Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia
    P Ballerini
    J Landman Parker
    I Laurendeau
    M Olivi
    M Vidaud
    M Adam
    G Leverger
    I Gerota
    YE Cayre
    I Bièche
    Leukemia, 2000, 14 : 1526 - 1528
  • [8] Real-time quantitative RT-PCR for detection of minimal residual disease in TEL-AMl1 positive childhood ALL.: Comparison with established DNA-based technique.
    Taube, T
    Eckert, C
    Körner, G
    Peter, A
    Einsiedel, HG
    Schmid, H
    Henze, G
    Seeger, K
    BLOOD, 2000, 96 (11) : 199B - 199B
  • [9] Real-time quantitative RT-PCR for detection of minimal residual disease in Tel-Aml1 positive childhood ALL.: Comparison with established DNA-based techniques.
    Taube, T
    Eckert, C
    Körner, G
    Henze, G
    Seeger, K
    LEUKEMIA, 2001, 15 (12) : 2009 - 2009
  • [10] Real-time PCR for quantitative detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL)
    Pongers-Willemse, MJ
    Verhagen, OJHM
    Tibbe, GJM
    Wijkhuijs, JM
    De Haas, V
    Van Wering, ER
    Van der Schoot, CE
    Van Dongen, JJM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 292 - 292
12345